ArticleBiotechnology and bioengineering2026
Integrating Green Process Engineering With Whole-Cell Catalysis to Intensify Sustainable Glucaric Acid Production.
Article in Biotechnology and bioengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study pioneered a whole-cell biocatalytic process using engineered Gluconobacter oxydans to produce glucaric acid (GA), a food additive, from glucuronic acid (GlcA). From a molecular perspective, molecular dynamics simulations have confirmed that van der Waals forces and hydrogen bond interactions in acidic environments effectively stabilized the structure-activity relationship of dehydrogenase and GlcA. Leveraging this insight, multi-strategies were implemented, including pH regulation, high-density biocatalysis, dehydrogenase overexpression, adaptive acclimation, bioreactor scale-up, and cell recycling technology, to significantly intensify the GA production. As a result, the recombinant G. oxydans achieved an effective production of 10.27 g/L GA with a productivity of 0.21 g/L/h, representing a 366.4% intensification over the unregulated system. In comparison with the highest level of biological methods reported to date, the process demonstrates greater economic feasibility and industrial application potential. This work elucidated the molecular mechanism of acid-intensified biocatalysis and provided a sustainable, industrially viable GA production platform.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.